Abstract
Background Breast parenchymal texture features, including gray scale variation (V), capture the patterns of texture variation on a mammogram and are associated with breast cancer risk, independent of mammographic density (MD). However, our knowledge on the genetic basis of these texture features is limited.
Methods We conducted a genome-wide association study of V in 7,040 European-ancestry women. Four V assessments representing different amounts of breast edge erosion and image resolutions were generated from digitized film mammograms. We used linear regression to test the single-nucleotide polymorphism (SNP)-phenotype associations adjusting for age, body mass index (BMI), MD phenotypes, and the top four genetic principal components. Multivariate phenotype association tests combining all four V assessments were performed. We further calculated genetic correlations and performed SNP-set tests of V with MD, breast cancer risk, and other breast cancer risk factors.
Results We identified three genome-wide significant loci associated with V: rs138141444 (6q24.1) in ECT2L, rs79670367 (8q24.22) in LINC01591, and rs113174754 (12q22) near PGAM1P5. 6q24.1 and 8q24.22 have not previously been associated with MD phenotypes or breast cancer risk, whilst 12q22 is a known locus for both MD and breast cancer risk. Among known MD and breast cancer risk SNPs, we identified four variants that were associated with V at the Bonferroni-corrected thresholds accounting for the number of SNPs tested: rs335189 (5q23.2) in PRDM6, rs13256025 (8p21.2) in EBF2, rs11836164 (12p12.1) near SSPN, and rs17817449 (16q12.2) in FTO. We observed significant genetic correlations between V and mammographic dense area (rg = 0.79, P = 5.91 × 10−5), percent density (rg = 0.73, P = 1.00 × 10−4), and adult BMI (rg = -0.36, P = 3.88 × 10−7). Additional significant relationships were observed for nondense area (z = -4.14, P = 3.42 × 10−5), estrogen receptor-positive breast cancer (z = 3.41, P = 6.41 × 10−4), and childhood body fatness (z = -4.91, P = 9.05 × 10−7) from the SNP-set tests.
Conclusions These findings provide new insights into the genetic basis of mammographic texture variation and their associations with MD, breast cancer risk, and other breast cancer risk factors.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by the National Cancer Institute (R01CA175080 and R01CA131332 to R.M.T., R01CA244670 to S.L., and R03CA224196 to X.J.), Avon Foundation for Women, Susan G. Komen for the Cure, and Breast Cancer Research Foundation. The Nurses' Health Study is supported by the National Cancer Institute (UM1CA186107, P01CA87969, and R01CA49449). The Nurses' Health Study II is supported by the National Cancer Institute (U01CA176726 and R01CA67262). The Mayo Mammography Health Study is supported by the National Cancer Institute (R01CA128931 and R01CA97396).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB of the Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health, and the Mayo Clinic gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
NHS/NHSII: The data that support the findings of this study are available from the Nurses' Health Studies, however they are not publicly available. Investigators interested in using the data can request access, and feasibility will be discussed at an investigators' meeting. Limits are not placed on scientific questions or methods, and there is no requirement for co-authorship. Additional data sharing information and policy details can be accessed at http://www.nurseshealthstudy.org/researchers. MMHS: The summary statistics generated from the current study are available from the corresponding author on reasonable request.
List of abbreviations
- BCAC
- Breast Cancer Association Consortium
- BMI
- body mass index
- DA
- dense area
- ER
- estrogen receptor
- GWAS
- genome-wide association study
- LD
- linkage disequilibrium
- MD
- mammographic density
- MMHS
- Mayo Mammography Health Study
- NDA
- nondense area
- NHS
- Nurses’ Health Study
- PC
- principal component
- PD
- percent density
- SNP
- single-nucleotide polymorphism
- VIF
- variance inflation factor
- V75H
- V with 25% erosion and high resolution
- V75L
- V with 25% erosion and low resolution
- V65H
- V with 35% erosion and high resolution
- V65L
- V with 35% erosion and low resolution